Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sugar Molecules, Not Antibodies, Used to Detect Influenza Viruses

By Labmedica staff writers
Posted on 14 Jul 2008
A fast, sensitive test uses sugar molecules rather than antibodies to detect influenza viruses. More...


Influenza is a contagious disease, which causes over 150 million infections per year in the United States alone. A new study has demonstrated glycoconjugate-based viral capture and a potential path for the discriminatory detection of intact influenza viruses in the presence of the innate enzymatic activity of viral nucleic acids (NAs).

The capture of intact influenza viruses is of potential benefit for clinical diagnostics.
Conventional tests for influenza viruses, including avian flu, rely on antibodies to recognize viruses. However, antibody-based tests can be expensive and require refrigeration to remain stable. The test using sugar molecules requires no refrigeration and it can be used in remote areas of the world where new influenza viruses frequently emerge.

In a new study, Jurgen Schmidt, Ph.D., from the Los Alamos National Laboratory (NM, USA), Suri Iyer, Ph.D., assistant professor in the department of chemistry, University of Cincinnati, (OH, USA), and colleagues developed artificial forms of sialic acid, a sugar molecule found on the surface of cells that flu viruses attach to when they attack humans.

The scientists synthesized robust, biotinylated biantennary sialylglycoconjugates and demonstrated their ability to differentiate between two types of influenza A strains. In laboratory tests, they showed that the highly selective artificial sugars could be used to quickly capture and recognize two common strains of influenza viruses, H1N1, which infects birds, and H3N2, which infects pigs and humans. They used the molecules to differentiate between two strains (Sydney and Beijing) commonly found in human infections without isolating the viral RNA or surface glycoproteins. The sugars remain stable for several months, can be produced in large quantities, and exhibit extended shelf- life.

The new method appeared in the July 2, 2008 issue of the Journal of the American Chemical Society, a weekly publication.


Related Links:
Los Alamos National Laboratory
University of Cincinnati

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.